Clinical Trial Update: Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety and efficacy of glepaglutide in Short Bowel Syndrome is currently active but not recruiting, with ongoing long-term ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Glepaglutide (glepaglutide)

Snippet

Sponsor: Zealand Pharma | Conditions: Short Bowel Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING